Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through Surgical Facility Services and Ancillary Services segments. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2020, it owned or operated a portfolio of 127 surgical facilities, including 110 ambulatory surgical centers and 17 surgical hospitals in 30 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
IPO Year: 2015
Exchange: NASDAQ
Website: surgerypartners.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
6/28/2024 | $31.00 | Outperform | Macquarie |
3/6/2024 | $35.00 | Equal Weight | Barclays |
11/14/2023 | $39.00 → $35.00 | Market Perform → Outperform | TD Cowen |
6/2/2023 | $42.00 → $45.00 | Neutral → Buy | BofA Securities |
5/12/2023 | $48.00 | Buy | Mizuho |
4/21/2023 | $43.00 | Overweight | Cantor Fitzgerald |
11/23/2022 | $58.00 → $48.00 | Outperform | RBC Capital Mkts |
6/15/2022 | $55.00 → $36.00 | Buy → Neutral | BofA Securities |
3/2/2022 | $50.00 → $55.00 | Neutral | JP Morgan |
3/2/2022 | $63.00 → $65.00 | Outperform | SVB Leerink |
4 - Surgery Partners, Inc. (0001638833) (Issuer)
4 - Surgery Partners, Inc. (0001638833) (Issuer)
3 - Surgery Partners, Inc. (0001638833) (Issuer)
4 - Surgery Partners, Inc. (0001638833) (Issuer)
4 - Surgery Partners, Inc. (0001638833) (Issuer)
4 - Surgery Partners, Inc. (0001638833) (Issuer)
4 - Surgery Partners, Inc. (0001638833) (Issuer)
4 - Surgery Partners, Inc. (0001638833) (Issuer)
4 - Surgery Partners, Inc. (0001638833) (Issuer)
4 - Surgery Partners, Inc. (0001638833) (Issuer)
8-K - Surgery Partners, Inc. (0001638833) (Filer)
10-Q - Surgery Partners, Inc. (0001638833) (Filer)
8-K - Surgery Partners, Inc. (0001638833) (Filer)
8-K - Surgery Partners, Inc. (0001638833) (Filer)
8-K - Surgery Partners, Inc. (0001638833) (Filer)
144 - Surgery Partners, Inc. (0001638833) (Subject)
10-Q - Surgery Partners, Inc. (0001638833) (Filer)
8-K - Surgery Partners, Inc. (0001638833) (Filer)
ARS - Surgery Partners, Inc. (0001638833) (Filer)
DEFA14A - Surgery Partners, Inc. (0001638833) (Filer)
SC 13G/A - Surgery Partners, Inc. (0001638833) (Subject)
SC 13G/A - Surgery Partners, Inc. (0001638833) (Subject)
SC 13G/A - Surgery Partners, Inc. (0001638833) (Subject)
SC 13D/A - Surgery Partners, Inc. (0001638833) (Subject)
SC 13G/A - Surgery Partners, Inc. (0001638833) (Subject)
SC 13G/A - Surgery Partners, Inc. (0001638833) (Subject)
SC 13G - Surgery Partners, Inc. (0001638833) (Subject)
SC 13G - Surgery Partners, Inc. (0001638833) (Subject)
SC 13D/A - Surgery Partners, Inc. (0001638833) (Subject)
SC 13G - Surgery Partners, Inc. (0001638833) (Subject)
Macquarie initiated coverage of Surgery Partners with a rating of Outperform and set a new price target of $31.00
Barclays initiated coverage of Surgery Partners with a rating of Equal Weight and set a new price target of $35.00
TD Cowen upgraded Surgery Partners from Market Perform to Outperform and set a new price target of $35.00 from $39.00 previously
BofA Securities upgraded Surgery Partners from Neutral to Buy and set a new price target of $45.00 from $42.00 previously
Mizuho initiated coverage of Surgery Partners with a rating of Buy and set a new price target of $48.00
Cantor Fitzgerald initiated coverage of Surgery Partners with a rating of Overweight and set a new price target of $43.00
RBC Capital Mkts reiterated coverage of Surgery Partners with a rating of Outperform and set a new price target of $48.00 from $58.00 previously
BofA Securities downgraded Surgery Partners from Buy to Neutral and set a new price target of $36.00 from $55.00 previously
JP Morgan reiterated coverage of Surgery Partners with a rating of Neutral and set a new price target of $55.00 from $50.00 previously
SVB Leerink reiterated coverage of Surgery Partners with a rating of Outperform and set a new price target of $65.00 from $63.00 previously
BRENTWOOD, Tenn., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the second quarter ended June 30, 2024. Revenues increased 14.2% to $762.1 million compared to the prior year period Same-facility revenues increased 9.9%Same-facility cases increased 3.9% Net loss attributable to Surgery Partners, Inc. was $15.5 million Adjusted EBITDA was $118.3 million, representing 18.1% growth compared to the prior year period Adjusted EBITDA margin was 15.5%, expanding 50 basis points from the prior year periodFull year guidance raised to greater than $3.
BRENTWOOD, Tenn., July 16, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2024 results before the market opens on Tuesday, August 6, 2024, to be followed by a conference call at 8:30 a.m. (Eastern Time) You can join the call as follows: Dial in number for live access: 1-800-579-2543 (domestic), 1-785-424-1789 (international)Conference ID for the live call: SPI2Q24Replay (available 3 hours after the call and available until August 20, 2024): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the replay: 11
BRENTWOOD, Tenn., May 07, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2024. Revenues increased 7.7% to $717.4 million compared to the prior year period Same-facility revenues increased 10.2% Net loss attributable to Surgery Partners, Inc. was $12.4 million Adjusted EBITDA was $97.5 million, representing 8.2% growth compared to the prior year period Adjusted EBITDA margin improved year-over-year to 13.6%Full year guidance raised to at least $3.05 billion in revenue and at least $505 million in Adjusted EBITDA
BRENTWOOD, Tenn., April 18, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2024 results before the market opens on Tuesday, May 7, 2024, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until May 21, 2024): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13746011 Interested investor
BRENTWOOD, Tenn., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the fourth quarter and full year ended December 31, 2023. Revenue increased 8.0% to $2.74 billion in the full-year 2023 and 4.0% to $735.4 million in the fourth quarter 2023, when compared to the comparable periods in 2022 Days adjusted same-facility revenues increased 11.3% in the full-year 2023 versus 2022Days adjusted same-facility revenues increased 8.1% in the fourth quarter 2023 versus 2022 Net loss attributable to common stockholders was $11.9 million for the full-year 2
BRENTWOOD, Tenn., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2023 results before the market opens on Monday, February 26, 2024, to be followed by a conference call at 8:30 a.m. (Eastern Time) You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until March 11, 2024): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13744429 Interested in
BRENTWOOD, Tenn., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading operator of surgical facilities, today announced financial results for the third quarter ended September 30, 2023. Revenues were $674.1 million representing 8.6% growth Days Adjusted Same-facility revenues increased 14.2% Net loss attributable to Surgery Partners was $4.9 million Adjusted EBITDA was $105.5 million, representing 9.7% growthAdjusted EBITDA margin improved year-over-year to 15.7% Equity earnings in unconsolidated affiliates increased 45.8% to $3.5 million Revenues from facilities not consolidated increased by 71.2% to $159.6 millionAdj
BRENTWOOD, Tenn., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its third quarter 2023 results before the market opens on Tuesday, November 7, 2023, to be followed by a conference call at 8:30 a.m. (Eastern Time) You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until November 21, 2023): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13741353 Interested
BRENTWOOD, Tenn., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced financial results for the second quarter ended June 30, 2023. Revenues were $667.6 million representing 8.5% growth and are inclusive of an $8 million cyber event headwind Same-facility revenues increased 8.3% on an unadjusted basis and approximately 10% adjusting for the cyber eventNon-consolidated minority interest revenue increased by over 30% Net income attributable to Surgery Partners was $18.9 million Adjusted EBITDA was $100.2 million, representing 16.4% growthAdjusted EBITDA margin improved by ove
BRENTWOOD, Tenn., July 19, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2023 results before the market opens on Tuesday, August 1, 2023, to be followed by a conference call at 8:30 a.m. (Eastern Time) You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until August 15, 2023): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13739956 Interested inv
PURCHASE, NY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today appointed Eric Evans to the company's board of directors. Mr. Evans, currently chief executive officer and director of Brentwood, TN-based Surgery Partners, Inc. (NASDAQ:SGRY), is a recognized healthcare and hospital executive with significant experience leading complex organizations operating at the intersection of care and technology. Mr. Evans joins the board following the retirement of Senator William Frist, M.D. earlier this year, and will serve on the board's compensation committee. David B. Snow, Jr., non-executive Chairman of the company's board,
PLANTATION, Fla., Aug. 12, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") provided a business update and announced the termination of employment of its Chief Financial Officer, William Larkin and the appointment of David Kretschmer as Interim Chief Financial Officer, effective today. The Company has implemented a transformation program with initiatives focused on its operations, growth, and capital. These initiatives are intended to support the Company's objectives with respect to patient access and experience, customer and partner engagement, financial sustainability, and employee well-being. The Company is receiving support from a globally recognized tr
BRENTWOOD, Tenn., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Members of management of Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, will be meeting with investors today, January 10, 2022, as part of the 40th Annual J.P. Morgan Healthcare Conference, including a virtual presentation at 5:15 p.m. ET. Based on results through November 2021, the Company is re-affirming its 2021 Adjusted EBITDA guidance of $325 million to $330 million and its 2021 Revenue guidance of 19% to 21% growth over 2020 results. The Company completed the deployment of approximately $185 million of capital in three acquisitions in December 20
BRENTWOOD, Tenn., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the second quarter ended June 30, 2024. Revenues increased 14.2% to $762.1 million compared to the prior year period Same-facility revenues increased 9.9%Same-facility cases increased 3.9% Net loss attributable to Surgery Partners, Inc. was $15.5 million Adjusted EBITDA was $118.3 million, representing 18.1% growth compared to the prior year period Adjusted EBITDA margin was 15.5%, expanding 50 basis points from the prior year periodFull year guidance raised to greater than $3.
BRENTWOOD, Tenn., July 16, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2024 results before the market opens on Tuesday, August 6, 2024, to be followed by a conference call at 8:30 a.m. (Eastern Time) You can join the call as follows: Dial in number for live access: 1-800-579-2543 (domestic), 1-785-424-1789 (international)Conference ID for the live call: SPI2Q24Replay (available 3 hours after the call and available until August 20, 2024): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the replay: 11
BRENTWOOD, Tenn., May 07, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2024. Revenues increased 7.7% to $717.4 million compared to the prior year period Same-facility revenues increased 10.2% Net loss attributable to Surgery Partners, Inc. was $12.4 million Adjusted EBITDA was $97.5 million, representing 8.2% growth compared to the prior year period Adjusted EBITDA margin improved year-over-year to 13.6%Full year guidance raised to at least $3.05 billion in revenue and at least $505 million in Adjusted EBITDA
BRENTWOOD, Tenn., April 18, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2024 results before the market opens on Tuesday, May 7, 2024, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until May 21, 2024): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13746011 Interested investor
BRENTWOOD, Tenn., March 26, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (the "Issuer"), priced $800,000,000 aggregate principal amount of its 7.250% senior unsecured notes due 2032 (the "Notes") in a previously announced private offering exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). The offering is expected to close on April 10, 2024, subject to certain customary closing conditions. The Notes will be guaranteed (the "Guarantees") on a senior unsecured basis by each domestic wholly-owned subs
BRENTWOOD, Tenn., March 26, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced today that Surgery Center Holdings, Inc., a wholly owned subsidiary of the Company (the "Issuer"), intends to offer, subject to market and other considerations, $600,000,000 aggregate principal amount of senior unsecured notes due 2032 (the "Notes"). The Notes will be guaranteed (the "Guarantees") on a senior unsecured basis by each domestic wholly-owned subsidiary of the Issuer that guarantees its obligations under its senior secured credit facilities. The terms of the Notes, including interest
BRENTWOOD, Tenn., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the fourth quarter and full year ended December 31, 2023. Revenue increased 8.0% to $2.74 billion in the full-year 2023 and 4.0% to $735.4 million in the fourth quarter 2023, when compared to the comparable periods in 2022 Days adjusted same-facility revenues increased 11.3% in the full-year 2023 versus 2022Days adjusted same-facility revenues increased 8.1% in the fourth quarter 2023 versus 2022 Net loss attributable to common stockholders was $11.9 million for the full-year 2
BRENTWOOD, Tenn., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2023 results before the market opens on Monday, February 26, 2024, to be followed by a conference call at 8:30 a.m. (Eastern Time) You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until March 11, 2024): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13744429 Interested in
BRENTWOOD, Tenn., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Members of management of Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, will be meeting with investors today, January 8, 2024, as part of the 42nd Annual J.P. Morgan Healthcare Conference, including a presentation at 5:15 p.m. ET. Based on results through November 2023, the Company is re-affirming its 2023 Adjusted EBITDA guidance of $436 million to $440 million and its 2023 Revenue guidance of approximately $2.75 billion. Additionally, consistent with managements commitment to driving mid-teens growth, the Company projects 2024 Adjusted EBITDA to be
BRENTWOOD, Tenn., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced that Eric Evans, Chief Executive Officer and Dave Doherty, Chief Financial Officer will meet with investors at the J.P. Morgan Healthcare Conference, including a presentation on Monday, January 8, 2024 at 5:15p.m. (Eastern Time). Interested investors and other parties may listen to a simultaneous webcast of the event by logging onto the Investor Relations section of the company's website at www.surgerypartners.com. The replay will also be available on this same website for a limited time
These eleven mid-cap stocks were the best performers in the last week. Are they in your portfolio? Virtu Financial, Inc. (NASDAQ:VIRT) shares jumped 30.04% after reporting better-than-expected Q2 financial results. V.F. Corporation (NYSE:VFC) stock upped 22.38% after the company announced it entered into a Stock and Asset Purchase Agreement to sell its Supreme brand to EssilorLuxottica (OTC: ESLOF) for $1.5 billion in cash. Several analysts raised their price forecasts on VFC. New Fortress Energy Inc. (NASDAQ:NFE) shares grew 20.19% after the company announced that it achieved First LNG for its initial Fast LNG asset located offshore Altamira, Mexico. Riot Platforms Inc (NASDAQ:
Cantor Fitzgerald analyst Sarah James reiterates Surgery Partners (NASDAQ:SGRY) with a Overweight and maintains $43 price target.
Cantor Fitzgerald analyst Sarah James reiterates Surgery Partners (NASDAQ:SGRY) with a Overweight and maintains $43 price target.
Cantor Fitzgerald analyst Sarah James reiterates Surgery Partners (NASDAQ:SGRY) with a Overweight and maintains $43 price target.
In the latest quarter, 4 analysts provided ratings for Surgery Partners (NASDAQ:SGRY), showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 2 0 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 2 0 0 0 0 3M Ago 0 1 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Surgery Partners, presenting an average target of $40.5, a high estimate of $50.00, and a low estimate of $31.00. Observing a downward trend, the
Macquarie analyst Tao Qiu initiates coverage on Surgery Partners (NASDAQ:SGRY) with a Outperform rating and announces Price Target of $31.
Citigroup analyst Jason Cassorla maintains Surgery Partners (NASDAQ:SGRY) with a Buy and lowers the price target from $42 to $38.
Shares of Beyond, Inc. (NYSE:BYON) fell sharply during Tuesday’s session following weaker-than-expected quarterly results. Beyond posted adjusted loss of $1.22 per share, versus estimates for a loss of 87 cents per share. The company’s sales came in at $382.281 million versus estimates of $389.264 million, according to data from Benzinga Pro. Beyond shares dipped 20.8% to $17.34 on Tuesday. Here are some other stocks moving in today’s mid-day session. Gainers Golden Sun Health Technology Group Limited (NASDAQ:GSUN) shares gained 94.7% to $5.60. Golden Sun Health Technology Group regained compliance with Nasdaq continued listing requirement. MMTec, Inc. (NASDAQ:MTC) gained